v3.25.4
Note 13 - Subsequent Events (Details Textual) - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended 12 Months Ended
Jan. 28, 2026
Jan. 20, 2026
Jan. 12, 2026
Feb. 13, 2026
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Jan. 27, 2026
Debt Conversion, Original Debt, Amount         $ 25,750 $ 0 $ 0  
Gain (Loss) on Extinguishment of Debt         (2,819) $ 0 $ (151)  
Conversion of 2030 Notes Into Common Stock [Member]                
Debt Conversion, Original Debt, Amount         $ 8,500      
Debt Conversion, Converted Instrument, Shares Issued (in shares)         1,197,288      
The 2030 Convertible Notes [Member]                
Debt Instrument, Convertible, Conversion Price (in dollars per share)         $ 7.12      
Subsequent Event [Member] | The 2030 Convertible Notes [Member] | Conversion of 2030 Notes Into Common Stock [Member]                
Debt Conversion, Original Debt, Amount       $ 15,100        
Debt Conversion, Converted Instrument, Shares Issued (in shares)       2,118,250        
Debt Instrument, Convertible, Conversion Price (in dollars per share)       $ 7.12        
Subsequent Event [Member] | Key Facility [Member]                
Line of Credit Facility, Fair Value of Amount Outstanding               $ 20,000
Subsequent Event [Member] | The 2026 Notes [Member]                
Gain (Loss) on Extinguishment of Debt $ 100              
Pelthos Therapeutics, Inc. [Member] | Debt Securities [Member] | Subsequent Event [Member]                
Payments to Acquire Investments   $ 20,000 $ 30,000